Extract
Calypte Receives Initial Order for the Middle East; Additional Orders Expected as Regulatory Approvals Received.
Business Editors/Health/Medical Writers
ALAMEDA, Calif.--(BUSINESS WIRE)--June 24, 2003 Calypte Biomedical Corporation (OTCBB:CYPT), the developer and marketer of the only two FDA approved HIV-1 antibody tests for use with urine samples, announced that it has re...See the full content of this document
Sponsored links
